| http://www.w3.org/ns/prov#value | - In terms of other tumors and other combinations, I???d say, we???re looking already at ??? have it just on carcinoma and hematologic relating piece with Nivolumab and we plan to start very soon a clinical program exploring both monotherapy and the Nivolumab YERVOY combination in the number of additional tumor types, strictly those with higher met needs such as head and neck glioblastoma, colon can
|
